Farnesyltransferase Haplodeficiency Reduces Neuropathology and Rescues Cognitive Function in a Mouse Model of Alzheimer Disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Farnesyltransferase Haplodeficiency Reduces Neuropathology and Rescues Cognitive Function in a Mouse Model of Alzheimer Disease
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 50, Pages 35952-35960
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-10-18
DOI
10.1074/jbc.m113.503904
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2013 Alzheimer's disease facts and figures
- (2013) Alzheimers & Dementia
- Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
- (2013) D. M. Holtzman et al. Cold Spring Harbor Perspectives in Medicine
- Isoprenoids and Related Pharmacological Interventions: Potential Application in Alzheimer’s Disease
- (2012) Ling Li et al. MOLECULAR NEUROBIOLOGY
- Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice
- (2011) Omar M. Khan et al. JOURNAL OF CLINICAL INVESTIGATION
- Pitavastatin decreases tau levels via the inactivation of Rho/ROCK
- (2011) Tadanori Hamano et al. NEUROBIOLOGY OF AGING
- Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation
- (2011) R.A. Mans et al. NEUROSCIENCE
- Control of synapse development and plasticity by Rho GTPase regulatory proteins
- (2011) Kimberley F. Tolias et al. PROGRESS IN NEUROBIOLOGY
- Isoprenoids, small GTPases and Alzheimer's disease
- (2010) Gero P. Hooff et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease
- (2010) Terry L. Lewis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Statins Promote the Degradation of Extracellular Amyloid β-Peptide by Microglia via Stimulation of Exosome-associated Insulin-degrading Enzyme (IDE) Secretion
- (2010) Irfan Y. Tamboli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- p120 catenin/αN-catenin are molecular targets in the neuroprotection and neuronal plasticity mediated by atorvastatin after focal cerebral ischemia
- (2010) Angel Céspedes-Rubio et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Small G Protein Signaling in Neuronal Plasticity and Memory Formation: The Specific Role of Ras Family Proteins
- (2010) Xiaojing Ye et al. NEURON
- Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer
- (2010) M. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene
- (2009) Pi-Lin Wang et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients
- (2009) Gunter P. Eckert et al. NEUROBIOLOGY OF DISEASE
- Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice
- (2009) R.A. Mans et al. NEUROSCIENCE
- Rac1 changes the substrate specificity of γ-secretase between amyloid precursor protein and Notch1
- (2008) Jung Hyun Boo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Neurotoxic Activation of Microglia Is Promoted by a Nox1-Dependent NADPH Oxidase
- (2008) C. Cheret et al. JOURNAL OF NEUROSCIENCE
- Geranylgeranyl pyrophosphate stimulates γ-secretase to increase the generation of Aβ and APP-CTFγ
- (2007) Yan Zhou et al. FASEB JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More